Income Statement IBM

Equities

IBM

US4592001014

IT Services & Consulting

Real-time Estimate Cboe BZX Other stock markets 10:18:14 2026-02-11 am EST			5-day change	1st Jan Change
283.69 ^USD	-2.77%		-0.89%	-3.28%

Feb. 10	RMX Industries, Inc. Announces Appointment of Sukumaran Nair to Advisory Board, Effective February 10, 2026	CI
Feb. 10	IBM introduces autonomous storage with new FlashSystem portfolio powered by Agentic AI	RE

8b640d8166723c17338a7f.lcsEK1OTf4_obg_T8gOuaCxb1S4msJqQ9hsBpUDQncE._b1BTxL0KuShWleFx23rLEAWoVhAiODaoFJH0DCzyK_h_mBSGOoS3IlDfA

Published financial data: IBM

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	72.49B	56.57B	59.88B	61.12B	62.04B
Finance Div. Revenues	1.13B	780M	651M	737M	709M
Other Revenues, Total	-	-	-	-	-
Total Revenues	73.62B	57.35B	60.53B	61.86B	62.75B
Cost of Goods Sold, Total	37.34B	25.33B	27.44B	27.18B	26.83B
Finance Div. Operating Exp.	708M	534M	406M	382M	369M
Gross Profit	35.58B	31.49B	32.69B	34.3B	35.55B
Selling General & Admin Expenses, Total	21.24B	19.8B	19.2B	18.48B	19.28B
R&D Expenses	6.33B	6.49B	6.57B	6.78B	7.48B
Other Operating Expenses	-584M	-577M	-642M	-852M	-996M
Other Operating Expenses, Total	26.99B	25.71B	25.12B	24.4B	25.76B
Operating Income	8.58B	5.77B	7.57B	9.9B	9.79B
Interest Expense, Total	-1.29B	-1.16B	-1.22B	-1.61B	-1.71B
Interest And Investment Income	105M	52M	162M	670M	747M
Net Interest Expenses	-1.18B	-1.1B	-1.05B	-937M	-965M
Currency Exchange Gains (Loss)	-12M	-1M	500M	-69M	20M
Other Non Operating Income (Expenses)	-473M	247M	104M	225M	261M
EBT, Excl. Unusual Items	6.92B	4.92B	7.12B	9.11B	9.1B
Restructuring Charges	-2.92B	-181M	-50M	-438M	-696M
Merger & Related Restructuring Charges	-13M	-43M	-18M	-33M	-123M
Gain (Loss) On Sale Of Investments	22M	133M	-278M	39M	20M
Gain (Loss) On Sale Of Assets	711M	35M	279M	8M	605M
Legal Settlements	-	-	-	-	-
Other Unusual Items	-77M	-22M	-5.89B	-	-3.11B
EBT, Incl. Unusual Items	4.64B	4.84B	1.16B	8.69B	5.8B
Income Tax Expense	-864M	124M	-626M	1.18B	-218M
Earnings From Continuing Operations	5.5B	4.71B	1.78B	7.51B	6.02B
Earnings Of Discontinued Operations	89M	1.03B	-143M	-12M	8M
Net Income to Company	5.59B	5.74B	1.64B	7.5B	6.02B
Net Income - (IS)	5.59B	5.74B	1.64B	7.5B	6.02B
Net Income to Common Incl Extra Items	5.59B	5.74B	1.64B	7.5B	6.02B
Net Income to Common Excl. Extra Items	5.5B	4.71B	1.78B	7.51B	6.02B
Per Share Items
Net EPS - Basic	6.28	6.41	1.82	8.23	6.53
Basic EPS - Continuing Operations	6.18	5.26	1.97	8.25	6.53
Basic Weighted Average Shares Outstanding	890M	896M	903M	911M	922M
Net EPS - Diluted	6.23	6.35	1.79	8.14	6.43
Diluted EPS - Continuing Operations	6.13	5.21	1.95	8.15	6.42
Diluted Weighted Average Shares Outstanding	897M	905M	912M	922M	937M
Normalized Basic EPS	4.85	3.43	4.93	6.25	6.17
Normalized Diluted EPS	4.82	3.4	4.88	6.18	6.07
Dividend Per Share	6.51	6.56	6.59	6.63	6.67
Payout Ratio	103.7	102.19	362.9	80.51	102.06
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	15.28B	12.19B	12.37B	13.63B	12.89B
EBITA	11.05B	8.3B	9.96B	11.52B	11.62B
EBIT	8.58B	5.77B	7.57B	9.9B	9.79B
EBITDAR	17.35B	13.63B	13.62B	14.92B	14.2B
Total Revenues (As Reported)	73.62B	57.35B	60.53B	61.86B	62.75B
Effective Tax Rate - (Ratio)	-18.63	2.56	-54.15	13.53	-3.76
Current Domestic Taxes	631M	535M	575M	687M	-183M
Current Foreign Taxes	1.83B	1.34B	1.68B	1.59B	2.3B
Total Current Taxes	2.46B	1.88B	2.25B	2.28B	2.12B
Deferred Domestic Taxes	862M	-1.73B	-3.13B	-1.53B	-2.54B
Deferred Foreign Taxes	-4.18B	-25M	252M	428M	203M
Total Deferred Taxes	-3.32B	-1.75B	-2.88B	-1.1B	-2.34B
Normalized Net Income	4.32B	3.07B	4.45B	5.7B	5.69B
Interest Capitalized	6M	3M	5M	9M	12M
Interest on Long-Term Debt	-	-	-	-	-
Non-Cash Pension Expense	964M	1.14B	6.46B	-147M	3.35B
Supplemental Operating Expense Items
Advertising Expense	1.54B	1.41B	1.33B	1.24B	1.17B
Selling and Marketing Expenses	1.54B	1.41B	1.33B	1.24B	1.17B
Research And Development Expense From Footnotes	6.33B	6.49B	6.57B	6.78B	7.48B
Net Rental Expense, Total	2.07B	1.44B	1.25B	1.29B	1.31B
Imputed Operating Lease Interest Expense	318M	221M	223M	293M	305M
Imputed Operating Lease Depreciation	1.75B	1.22B	1.02B	999M	1B
Stock-Based Comp., COGS (Total)	153M	145M	164M	190M	223M
Stock-Based Comp., R&D Exp. (Total)	198M	218M	258M	328M	398M
Stock-Based Comp., SG&A Exp. (Total)	586M	555M	566M	616M	690M
Stock-Based Comp., Other (Total)	-	64M	-	-	-
Total Stock-Based Compensation	937M	982M	988M	1.13B	1.31B

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	13.21B	6.65B	7.89B	13.07B	13.95B
Short Term Investments	600M	600M	852M	373M	644M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	13.81B	7.25B	8.74B	13.44B	14.59B
Accounts Receivable, Total	7.63B	7.22B	7B	7.72B	7.24B
Other Receivables	714M	1B	677M	629M	918M
Total Receivables	8.34B	8.22B	7.68B	8.35B	8.16B
Inventory	1.84B	1.65B	1.55B	1.16B	1.29B
Prepaid Expenses	1.62B	2.64B	1.88B	1.77B	1.51B
Finance Division Loans and Leases Current	10.89B	7.22B	6.85B	6.1B	6.26B
Finance Division Other Current Assets, Total	-	793M	939M	692M	900M
Restricted Cash	463M	307M	103M	21M	214M
Other Current Assets, Total	2.19B	1.46B	1.38B	1.38B	1.56B
Total Current Assets	39.16B	29.54B	29.12B	32.91B	34.48B
Gross Property Plant And Equipment	37.86B	23.31B	21.57B	21.34B	20.89B
Accumulated Depreciation	-23.14B	-14.39B	-13.36B	-12.62B	-11.96B
Net Property Plant And Equipment	14.73B	8.92B	8.21B	8.72B	8.93B
Long-term Investments	226M	206M	1.61B	1.59B	1.69B
Goodwill	59.62B	55.64B	55.95B	60.18B	60.71B
Other Intangibles, Total	13.8B	12.51B	11.18B	11.04B	10.66B
Finance Division Loans and Leases Long-Term	7.09B	5.42B	5.81B	5.77B	5.35B
Deferred Tax Assets Long-Term	9.24B	7.37B	6.26B	6.66B	6.98B
Deferred Charges Long-Term	2.45B	924M	866M	842M	788M
Other Long-Term Assets, Total	9.66B	11.47B	8.24B	7.54B	7.59B
Total Assets	156B	132B	127B	135B	137B
Liabilities
Accounts Payable, Total	4.91B	3.96B	4.05B	4.13B	4.03B
Accrued Expenses, Total	9.5B	6.9B	7.05B	6.73B	7.05B
Short-term Borrowings	130M	22M	8M	-	30M
Current Portion of Long-Term Debt	6.96B	6.73B	4.68B	6.3B	4.86B
Current Portion of Leases	1.45B	1.01B	949M	941M	966M
Current Income Taxes Payable	3.3B	2.29B	2.2B	2.27B	2.03B
Unearned Revenue Current, Total	13.04B	12.65B	12.03B	13.45B	13.91B
Other Current Liabilities	587M	60M	546M	295M	261M
Total Current Liabilities	39.87B	33.62B	31.5B	34.12B	33.14B
Long-Term Debt	54.16B	44.85B	46.02B	49.74B	49.08B
Long-Term Leases	3.77B	2.52B	2.35B	2.95B	3.46B
Unearned Revenue Non Current	4.3B	3.58B	3.5B	3.53B	3.62B
Pension & Other Post Retirement Benefits	18.25B	14.44B	9.6B	10.81B	9.43B
Deferred Tax Liability Non Current	5.47B	3.96B	2.29B	1.15B	815M
Other Non Current Liabilities	9.43B	10.04B	9.95B	10.33B	10.23B
Total Liabilities	135B	113B	105B	113B	110B
Common Stock, Total	56.56B	57.32B	58.34B	59.64B	61.38B
Retained Earnings	163B	154B	150B	151B	151B
Treasury Stock	-169B	-169B	-169B	-170B	-170B
Comprehensive Income and Other	-29.34B	-23.24B	-16.74B	-18.76B	-15.27B
Total Common Equity	20.6B	18.9B	21.94B	22.53B	27.31B
Minority Interest	129M	95M	77M	80M	86M
Total Equity	20.73B	19B	22.02B	22.61B	27.39B
Total Liabilities And Equity	156B	132B	127B	135B	137B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	894M	899M	907M	917M	927M
ECS Total Common Shares Outstanding	893M	898M	906M	915M	926M
Book Value / Share	23.07	21.05	24.22	24.63	29.48
Tangible Book Value	-52.82B	-49.25B	-45.19B	-48.68B	-44.06B
Tangible Book Value Per Share	-59.17	-54.84	-49.87	-53.2	-47.57
Total Debt	66.47B	55.14B	54.01B	59.94B	58.4B
Net Debt	52.66B	47.89B	45.28B	46.49B	43.8B
Debt Equivalent of Unfunded Proj. Benefit Obligation	7.01B	1.45B	-711M	1.22B	-87M
Debt Equivalent Oper. Leases	16.54B	11.5B	9.98B	10.34B	10.47B
Minority Interest, Total (Incl. Fin. Div)	129M	95M	77M	80M	86M
Equity Method Investments, Total	172M	159M	142M	125M	108M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Work In Process, Total	1.65B	1.44B	1.39B	1.08B	1.16B
Inventories - Finished Goods, Total	190M	208M	158M	78M	134M
Land - (BS)	381M	224M	213M	182M	179M
Buildings, Total	9.42B	6.05B	5.68B	5.33B	4.82B
Machinery, Total	19.68B	13.81B	12.8B	12.61B	12.69B
Full Time Employees	346K	282K	288K	282K	270K
Accumulated Allowance for Doubtful Accounts (Supple)	351M	218M	233M	192M	114M
Order Backlog	111B	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	5.59B	5.74B	1.64B	7.5B	6.02B
Depreciation & Amortization - CF	4.23B	3.89B	2.41B	2.11B	2.17B
Amortization of Goodwill and Intangible Assets - (CF)	2.47B	2.53B	2.4B	1.63B	1.83B
Depreciation & Amortization, Total	6.7B	6.42B	4.8B	3.74B	4B
Amortization of Deferred Charges, Total - (CF)	-	-	-	660M	669M
(Gain) Loss From Sale Of Asset	-70M	-307M	-122M	-170M	-652M
Stock-Based Compensation (CF)	937M	982M	987M	1.13B	1.31B
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	-3.2B	-2B	3.17B	-1.11B	783M
Change In Accounts Receivable	5.3B	1.37B	-539M	725M	-374M
Change In Inventories	-209M	138M	71M	390M	-166M
Change In Accounts Payable	138M	85M	213M	65M	-13M
Change in Other Net Operating Assets	3.02B	367M	216M	1B	1.87B
Cash from Operations	18.2B	12.8B	10.44B	13.93B	13.44B
Capital Expenditure	-2.62B	-2.06B	-1.35B	-1.24B	-1.05B
Sale of Property, Plant, and Equipment	188M	387M	111M	321M	557M
Cash Acquisitions	-336M	-3.29B	-2.35B	-5.08B	-3.29B
Divestitures	503M	114M	1.27B	-4M	698M
Sale (Purchase) of Intangible assets	-612M	-706M	-626M	-565M	-637M
Investment in Marketable and Equity Securities, Total	-628M	-414M	-1.26B	-496M	-1.22B
Net (Increase) Decrease in Loans Originated / Sold - Investing	475M	-	-	-	-
Other Investing Activities, Total	-	-1M	-	1M	-
Cash from Investing	-3.03B	-5.98B	-4.2B	-7.07B	-4.94B
Short Term Debt Issued, Total	-	-	217M	-	30M
Long-Term Debt Issued, Total	10.5B	522M	7.8B	9.59B	5.7B
Total Debt Issued	10.5B	522M	8.02B	9.59B	5.74B
Short Term Debt Repaid, Total	-853M	-40M	-	-7M	-
Long-Term Debt Repaid, Total	-13.36B	-8.6B	-6.8B	-5.08B	-6.62B
Total Debt Repaid	-14.22B	-8.64B	-6.8B	-5.09B	-6.62B
Issuance of Common Stock	-	-	-	-	745M
Repurchase of Common Stock	-302M	-319M	-407M	-402M	-651M
Common Dividends Paid	-5.8B	-5.87B	-5.95B	-6.04B	-6.15B
Common & Preferred Stock Dividends Paid	-5.8B	-5.87B	-5.95B	-6.04B	-6.15B
Other Financing Activities, Total	92M	949M	176M	176M	-146M
Cash from Financing	-9.72B	-13.35B	-4.96B	-1.77B	-7.08B
Foreign Exchange Rate Adjustments	-87M	-185M	-244M	9M	-359M
Miscellaneous Cash Flow Adjustments	-	-	1M	-	1M
Net Change in Cash	5.36B	-6.72B	1.03B	5.1B	1.07B
Supplemental Items
Cash Interest Paid	1.83B	1.51B	1.4B	1.67B	1.98B
Cash Income Tax Paid (Refund)	2.25B	2.1B	1.86B	1.56B	1.72B
Levered Free Cash Flow	16.97B	4.74B	9.71B	10.82B	9.33B
Unlevered Free Cash Flow	17.77B	5.47B	10.47B	11.82B	10.4B
Change In Net Working Capital	-8B	2.77B	-1.92B	-1.92B	15M
Net Debt Issued / Repaid	-3.71B	-8.12B	1.22B	4.5B	-880M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.48	2.51	3.65	4.71	4.49
Return on Total Capital	6.08	4.51	6.3	7.8	7.27
Return On Equity %	26.38	23.73	8.69	33.67	24.06
Return on Common Equity	26.55	23.86	8.73	33.79	24.14
Margin Analysis
Gross Profit Margin %	48.32	54.9	54	55.45	56.65
SG&A Margin	28.85	34.53	31.71	29.88	30.73
EBITDA Margin %	20.75	21.25	20.43	22.04	20.53
EBITA Margin %	15.01	14.47	16.46	18.63	18.51
EBIT Margin %	11.66	10.06	12.5	16	15.6
Income From Continuing Operations Margin %	7.47	8.22	2.94	12.15	9.59
Net Income Margin %	7.59	10.01	2.71	12.13	9.6
Net Avail. For Common Margin %	7.47	8.22	2.94	12.15	9.59
Normalized Net Income Margin	5.87	5.36	7.35	9.21	9.07
Levered Free Cash Flow Margin	23.04	8.27	16.04	17.49	14.86
Unlevered Free Cash Flow Margin	24.14	9.53	17.3	19.11	16.57
Asset Turnover
Asset Turnover	0.48	0.4	0.47	0.47	0.46
Fixed Assets Turnover	4.95	6.14	7.07	7.31	7.11
Receivables Turnover (Average Receivables)	9.07	8.42	8.42	8.3	8.3
Inventory Turnover (Average Inventory)	21.6	14.64	17.14	20.04	21.9
Short Term Liquidity
Current Ratio	0.98	0.88	0.92	0.96	1.04
Quick Ratio	0.83	0.68	0.74	0.82	0.88
Operating Cash Flow to Current Liabilities	0.46	0.38	0.33	0.41	0.41
Days Sales Outstanding (Average Receivables)	40.37	43.36	43.37	43.96	44.11
Days Outstanding Inventory (Average Inventory)	16.95	24.93	21.29	18.22	16.71
Average Days Payable Outstanding	47.77	57.92	53.44	55.75	55.42
Cash Conversion Cycle (Average Days)	9.55	10.37	11.22	6.43	5.41
Long Term Solvency
Total Debt/Equity	320.7	290.27	245.28	265.05	213.18
Total Debt / Total Capital	76.23	74.38	71.04	72.61	68.07
LT Debt/Equity	279.5	249.42	219.69	233	191.8
Long-Term Debt / Total Capital	66.44	63.91	63.63	63.83	61.24
Total Liabilities / Total Assets	86.71	85.61	82.69	83.28	80.03
EBIT / Interest Expense	6.66	5	6.22	6.16	5.72
EBITDA / Interest Expense	13.47	11.8	11.2	9.29	8.29
(EBITDA - Capex) / Interest Expense	11.44	10.01	10.09	8.51	7.68
Total Debt / EBITDA	3.83	4.05	3.97	4.02	4.11
Net Debt / EBITDA	3.04	3.51	3.33	3.12	3.09
Total Debt / (EBITDA - Capex)	4.51	4.77	4.4	4.38	4.44
Net Debt / (EBITDA - Capex)	3.58	4.14	3.69	3.4	3.33
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-4.57	3.94	5.54	2.2	1.44
Gross Profit, 1 Yr. Growth %	-2.5	2.01	3.82	4.93	3.65
EBITDA, 1 Yr. Growth %	-9.29	-0.83	1.48	16.3	1.15
EBITA, 1 Yr. Growth %	-12.53	2.94	20.01	23.71	0.76
EBIT, 1 Yr. Growth %	-20.41	3.15	31.1	30.77	-1.16
Earnings From Cont. Operations, 1 Yr. Growth %	-41.7	19.86	-62.19	321.66	-19.95
Net Income, 1 Yr. Growth %	-40.73	2.74	-71.46	357.72	-19.71
Normalized Net Income, 1 Yr. Growth %	-35.36	7.71	44.8	23.58	0.3
Diluted EPS Before Extra, 1 Yr. Growth %	-41.97	18.86	-62.57	317.95	-21.23
Accounts Receivable, 1 Yr. Growth %	-8.77	16.25	-3.04	10.19	-6.24
Inventory, 1 Yr. Growth %	13.59	-9	-5.88	-25.19	11.02
Net Property, Plant and Equip., 1 Yr. Growth %	-1.87	-8.75	-7.9	6.2	2.38
Total Assets, 1 Yr. Growth %	2.49	-15.37	-3.6	6.29	1.43
Tangible Book Value, 1 Yr. Growth %	0.38	5	-8.25	7.73	-9.49
Common Equity, 1 Yr. Growth %	-1.17	-8.23	16.1	2.68	21.19
Cash From Operations, 1 Yr. Growth %	23.2	-29.68	-18.45	33.5	-3.49
Capital Expenditures, 1 Yr. Growth %	14.52	-21.24	-34.72	-7.5	-15.82
Levered Free Cash Flow, 1 Yr. Growth %	0.79	-69.32	104.64	11.42	-13.84
Unlevered Free Cash Flow, 1 Yr. Growth %	0.56	-66.4	91.52	12.92	-12.11
Dividend Per Share, 1 Yr. Growth %	1.24	0.77	0.61	0.61	0.6
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-3.82	-0.32	4.74	3.86	1.82
Gross Profit, 2 Yr. CAGR %	-1.86	-0.08	2.91	4.37	4.29
EBITDA, 2 Yr. CAGR %	-7.09	-5.32	4.36	9.79	9.36
EBITA, 2 Yr. CAGR %	-12.91	-5.97	18.2	24.6	11.96
EBIT, 2 Yr. CAGR %	-19.41	-12.5	27.4	33.13	14.08
Earnings From Cont. Operations, 2 Yr. CAGR %	-20.59	-18.79	-32.68	26.27	83.72
Net Income, 2 Yr. CAGR %	-19.97	-21.96	-45.85	14.29	91.7
Normalized Net Income, 2 Yr. CAGR %	-21.91	-12.67	66.35	39.19	13.48
Diluted EPS Before Extra, 2 Yr. CAGR %	-19.71	-19.3	-33.3	25.07	81.45
Accounts Receivable, 2 Yr. CAGR %	-1.74	-7.05	6.17	3.36	1.64
Inventory, 2 Yr. CAGR %	4.56	0.92	-7.45	-16.09	-8.87
Net Property, Plant and Equip., 2 Yr. CAGR %	16.81	-22.92	-8.32	-1.1	4.27
Total Assets, 2 Yr. CAGR %	12.43	-6.87	-9.68	1.22	3.83
Tangible Book Value, 2 Yr. CAGR %	53.02	-3.25	-1.85	-0.58	-1.26
Common Equity, 2 Yr. CAGR %	10.74	-4.77	3.22	9.19	11.55
Cash From Operations, 2 Yr. CAGR %	9.25	-6.92	-24.27	4.34	13.51
Capital Expenditures, 2 Yr. CAGR %	-12.19	-5.03	-28.3	-22.3	-11.76
Levered Free Cash Flow, 2 Yr. CAGR %	61.77	-43.39	-19.22	52.91	-1.85
Unlevered Free Cash Flow, 2 Yr. CAGR %	60.08	-40.89	-18.3	48.68	-0.22
Dividend Per Share, 2 Yr. CAGR %	2.39	1.01	0.61	0.61	0.61
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-2.38	-10.35	1.6	3.88	3.05
Gross Profit, 3 Yr. CAGR %	-1.25	-5.18	1.21	3.58	4.13
EBITDA, 3 Yr. CAGR %	-1.98	-11.69	-3.11	6.27	4.45
EBITA, 3 Yr. CAGR %	-5.75	-17.1	1.99	17.35	16.12
EBIT, 3 Yr. CAGR %	-9.76	-24.13	0.12	28.51	20.58
Earnings From Cont. Operations, 3 Yr. CAGR %	-1.51	-18.55	-37.06	24.09	8.47
Net Income, 3 Yr. CAGR %	-0.95	-13.02	-44.2	10.3	1.6
Normalized Net Income, 3 Yr. CAGR %	-15.35	-24.33	3.37	52.46	24.62
Diluted EPS Before Extra, 3 Yr. CAGR %	-0.04	-18.19	-37.53	22.97	7.21
Accounts Receivable, 3 Yr. CAGR %	-6.72	-2.94	-5.73	7.49	0.06
Inventory, 3 Yr. CAGR %	5.12	-0.66	-1.4	-13.79	-7.88
Net Property, Plant and Equip., 3 Yr. CAGR %	9.83	-6.17	-18.2	-3.72	0.05
Total Assets, 3 Yr. CAGR %	7.56	2.28	-5.79	-4.64	1.29
Tangible Book Value, 3 Yr. CAGR %	32.05	29.73	-4.95	1.25	-3.65
Common Equity, 3 Yr. CAGR %	5.39	4.01	1.73	3.04	13.05
Cash From Operations, 3 Yr. CAGR %	2.85	-5.67	-10.94	-8.52	1.66
Capital Expenditures, 3 Yr. CAGR %	-6.75	-15.31	-16.18	-21.95	-20.2
Levered Free Cash Flow, 3 Yr. CAGR %	28.25	-9.88	-13.12	-10.08	26.32
Unlevered Free Cash Flow, 3 Yr. CAGR %	28.24	-7.63	-12.53	-8.99	24.8
Dividend Per Share, 3 Yr. CAGR %	3.33	1.84	0.82	0.61	0.61
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-2.07	-6.42	-5.22	-4.92	1.69
Gross Profit, 5 Yr. CAGR %	-2.65	-3.95	-2.42	-1.47	2.43
EBITDA, 5 Yr. CAGR %	-5.59	-8.06	-5.28	-5.09	-1.07
EBITA, 5 Yr. CAGR %	-9	-11.98	-5.48	-4.59	4.35
EBIT, 5 Yr. CAGR %	-12.27	-16.44	-8.32	-5.63	5.36
Earnings From Cont. Operations, 5 Yr. CAGR %	-16.27	-16.88	-20.91	-2.94	-3.39
Net Income, 5 Yr. CAGR %	-15.78	-13.52	-22.21	-2.98	-8.58
Normalized Net Income, 5 Yr. CAGR %	-16.28	-18.21	-8.99	-4.28	7.16
Diluted EPS Before Extra, 5 Yr. CAGR %	-14.72	-15.91	-20.5	-3.05	-4.31
Accounts Receivable, 5 Yr. CAGR %	-1.75	-4.68	-5.71	-0.47	-2.85
Inventory, 5 Yr. CAGR %	3.47	1.21	-0.39	-7.15	-4.46
Net Property, Plant and Equip., 5 Yr. CAGR %	6.54	-3.81	-5.88	-4.17	-9.86
Total Assets, 5 Yr. CAGR %	7.14	2.36	0.3	1.85	-2.06
Tangible Book Value, 5 Yr. CAGR %	19.98	16.82	14.53	16.63	-3.49
Common Equity, 5 Yr. CAGR %	7.63	0.71	4.52	6.05	5.55
Cash From Operations, 5 Yr. CAGR %	1.07	-5.62	-9	-1.79	-1.86
Capital Expenditures, 5 Yr. CAGR %	-6.06	-10.38	-16.05	-18.18	-14.44
Levered Free Cash Flow, 5 Yr. CAGR %	14.17	-12.29	3.84	10.78	-8.83
Unlevered Free Cash Flow, 5 Yr. CAGR %	14.48	-10.53	4.44	11.26	-7.85
Dividend Per Share, 5 Yr. CAGR %	5.42	3.59	2.24	1.32	0.74